Inhibition of Mayaro virus infection by bovine lactoferrin

Carlos A M Carvalho1, Ivanildo P Sousa2, Jerson L Silva1

  • 1Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brazil.

Virology
|March 11, 2014
PubMed

Insights

Bovine lactoferrin (bLf) effectively inhibits Mayaro virus (MAYV) infection by blocking cellular entry. This study highlights bLf as a potential antiviral strategy against this emerging neotropical pathogen.

Area of Science:

  • Virology
  • Immunology
  • Biochemistry

Background:

  • Mayaro virus (MAYV) is an arbovirus causing debilitating febrile illness outbreaks in South America.
  • MAYV is transitioning to urban settings, posing a growing public health threat.
  • No effective antiviral treatments are currently available for MAYV infections.

Purpose of the Study:

  • To investigate the potential antiviral activity of bovine lactoferrin (bLf) against Mayaro virus (MAYV).
  • To determine the mechanism by which bLf affects MAYV infection.

Main Methods:

  • In vitro assessment of bLf's effect on MAYV infection.
  • Evaluation of bLf's impact on different stages of the viral life cycle.
  • Analysis of bLf's cellular binding mechanism, focusing on glycosaminoglycans.

Main Results:

  • Bovine lactoferrin (bLf) demonstrated significant inhibition of MAYV infection without causing cytotoxicity.
  • Virus entry into host cells was identified as the primary stage inhibited by bLf.
  • bLf binding to cells was dependent on sulfated glycosaminoglycans, indicating a blockade of these molecules.

Conclusions:

  • Bovine lactoferrin (bLf) exhibits potent antiviral properties against Mayaro virus (MAYV).
  • bLf interferes with MAYV cell entry by targeting cell-surface glycosaminoglycans.
  • bLf represents a promising therapeutic candidate for combating MAYV, an emerging neotropical pathogen.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
106
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
58